All Pharma News
price-trendAsk Us
Lundbeck adds a Parkinson`s flop to its list , writing off a $1.1 billion deal

Lundbeck adds a Parkinson`s flop to its list , writing off a $1.1 billion deal
John Carroll ENDPTS
31 Mar 2020
Share Share
Forbion raises $270M to tap the potential of European biotech plays

Forbion raises $270M to tap the potential of European biotech plays
Amber Tong ENDPTS
11 Jul 2018
Share Share
Lundbeck To Acquire Prexton Therapeutics

Lundbeck To Acquire Prexton Therapeutics
GLOBENEWSWIRE
18 Mar 2018
Share Share